{"name":"LaNova Medicines Zhejiang Co., Ltd.","slug":"lanova-medicines-zhejiang-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LM-302 Injection","genericName":"LM-302 Injection","slug":"lm-302-injection","indication":"Treatment of metastatic non-small cell lung cancer","status":"phase_3"}]}],"pipeline":[{"name":"LM-302 Injection","genericName":"LM-302 Injection","slug":"lm-302-injection","phase":"phase_3","mechanism":"LM-302 Injection is a monoclonal antibody targeting a specific molecular target.","indications":["Treatment of metastatic non-small cell lung cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOR0pvMzJlOGk4UVB3RU9weFdwWGZVSW90SGlVN2laVFpHc0MtQnlIdW9GMjlDMV85Ui1WU0lrWWRNeGJPTnozUnI5VEFnU1RGNkg3bGI4NkgyUjhEeWw2bnptbjFkeDhwQjRUVk1fUE5BQ25TVFl2cTdsc1JyckRSb3hKdFd1NW56Nm9LZDlseFFiQld1ckV6d3JmYk1ybVoyYXlGQlZVc1IycGFyck45RkgyZVIxYm1tY21vaUtJTkpBZUVQUXhxNm5WWXFnNTg?oc=5","date":"2025-07-15","type":"deal","source":"Reuters","summary":"Sino Biopharmaceutical to acquire LaNova Medicines for up to $951 million - Reuters","headline":"Sino Biopharmaceutical to acquire LaNova Medicines for up to $951 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPQUd0aURFd0JOb3JDZldacGhMUDBFLUFzMHlFUXZTWW9NVGpITldUS0VRTUx1SE5tU21YLTlveU5Hd2Q2SGViUThwNmk4LW9ubTExaG5jenpGV3R0WlpObFdxUEQyeWxYUlpyT0FqeDA4Y1V6XzJKWEZMY3BDaW9vRGxmUm0zbDdzM0pZRzdRTGFUUnp0ZjY4ZVlPbWhSS2FYZkM3RmVuLVAteDQ?oc=5","date":"2025-05-19","type":"deal","source":"Bloomberg.com","summary":"Pfizer Licenses 3SBio Cancer Drug From China for Record $1.2 Billion - Bloomberg.com","headline":"Pfizer Licenses 3SBio Cancer Drug From China for Record $1.2 Billion","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}